Anti-cN-1A Ab (NT5c1A) IBM
Use
The Anti-cN-1A Ab (NT5c1A) IBM test is used to detect the presence of antibodies against the cytoplasmic 5'-nucleotidase 1A (cN-1A) in serum, which is associated with sporadic inclusion body myositis (sIBM), a progressive muscle disorder. The presence of these antibodies can aid in the diagnosis of sIBM, assist in differentiating it from other forms of inflammatory myopathies, and provide valuable information for treatment planning and prognosis.
Special Instructions
Not provided.
Limitations
This test has not been cleared or approved by the FDA, and its results should be interpreted in conjunction with clinical findings and other diagnostic procedures. Gross hemolysis, lipemia, icterus, or bacterial contamination of the sample can lead to rejection. Other specimen types apart from serum are not acceptable. The minimum specimen volume does not allow for repeat testing, so care must be taken to collect the adequate volume.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
cN-1A
Protein
LOINC Codes
- 96562-4 - cN-1A Ab Ser IA-aCnc
- 96562-4 - cN-1A Ab Ser IA-aCnc
Result Turnaround Time
9-14 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
0.5 mL
Container
Plastic vial
Collection Instructions
Within 1 hour of specimen collection, centrifuge and aliquot 2 mL of serum into a plastic vial. Send refrigerated.
Storage Instructions
Refrigerated storage preferred; ambient up to 7 days and frozen up to 60 days are acceptable.
Causes for Rejection
Gross hemolysis, lipemia, icterus, or bacterial contamination; anything other than serum; inadequate volume.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 60 days |